CK a finalist in the EyeforPharma Awards
CK Group is delighted to announce that CK Aspire has been named a finalist in the EyeforPharma awards, in the ‘Most Valuable Patient Initiative’ category, for their collaboration with GSK on the Salford Lung Study.
